FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135953726> ?p ?o ?g. }

• W2135953726 endingPage "47" @default.
• W2135953726 startingPage "47" @default.
• W2135953726 abstract "The aim of this investigation was to assess the effect of galantamine, an acetylcholinesterase inhibitor and allosteric modulator of nicotinic receptors, on brain atrophy in individuals with mild cognitive impairment (MCI), and to assess effect modification by apolipoprotein E (APOE) genotype.We used data from the Galantamine-International-11 (Gal-Int-11) trial, a 24-month, randomized, double blind, placebo-controlled, flexible-dose (16 to 24 mg daily) study in patients with MCI. Brain magnetic resonance imaging (MRI), including a 3-dimensional T1-weighted gradient echo volumetric sequence, was performed at screening and at 24 months. We recorded whole brain and hippocampal volumes, and calculated annual atrophy rates. Linear regression analysis was used to calculate adjusted mean differences in the rate of whole brain and hippocampal atrophy, between MCI patients treated with galantamine and with placebo. Additionally, we performed stratified analyses according to APOE genotype.Data from 364 MCI patients with 24-month MRI data (galantamine, n = 176; placebo, n = 188) were included in the volumetric analysis. Subjects treated with galantamine demonstrated a lower rate of whole brain atrophy compared to those treated with placebo (adjusted mean difference 0.18% per year (95% confidence interval (CI) 0.04; 0.30)). Stratified analyses according to APOE genotype, showed that this effect was confined to patients who carried an APOE ϵ4 allele (adjusted mean difference 0.28% per year (95% CI 0.07; 0.50)). Rates of hippocampal atrophy did not differ significantly between study groups.Patients with MCI who were treated with galantamine demonstrated a lower rate of whole brain atrophy, but not of hippocampal atrophy, over a 24-month treatment period, compared to those treated with placebo. This protective effect of galantamine on whole brain atrophy rate in MCI was only present in APOE ϵ4 carriers." @default.
• W2135953726 created "2016-06-24" @default.
• W2135953726 creator A5009252002 @default.
• W2135953726 creator A5018836358 @default.
• W2135953726 creator A5019926739 @default.
• W2135953726 creator A5025870220 @default.
• W2135953726 creator A5038926287 @default.
• W2135953726 creator A5039252548 @default.
• W2135953726 creator A5062479277 @default.
• W2135953726 creator A5064378373 @default.
• W2135953726 date "2014-01-01" @default.
• W2135953726 modified "2023-09-30" @default.
• W2135953726 title "The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial" @default.
• W2135953726 cites W1941904320 @default.
• W2135953726 cites W1983673952 @default.
• W2135953726 cites W1990928631 @default.
• W2135953726 cites W1991952617 @default.
• W2135953726 cites W2000178490 @default.
• W2135953726 cites W2025290060 @default.
• W2135953726 cites W2027550281 @default.
• W2135953726 cites W2028436804 @default.
• W2135953726 cites W2031655994 @default.
• W2135953726 cites W2047125512 @default.
• W2135953726 cites W2067031806 @default.
• W2135953726 cites W2077887990 @default.
• W2135953726 cites W2084862116 @default.
• W2135953726 cites W2087159877 @default.
• W2135953726 cites W2094102206 @default.
• W2135953726 cites W2098265084 @default.
• W2135953726 cites W2101282109 @default.
• W2135953726 cites W2104517703 @default.
• W2135953726 cites W2107327698 @default.
• W2135953726 cites W2111357727 @default.
• W2135953726 cites W2114136027 @default.
• W2135953726 cites W2115017507 @default.
• W2135953726 cites W2117134611 @default.
• W2135953726 cites W2120695611 @default.
• W2135953726 cites W2122692162 @default.
• W2135953726 cites W2124006321 @default.
• W2135953726 cites W2129047299 @default.
• W2135953726 cites W2131525108 @default.
• W2135953726 cites W2143158947 @default.
• W2135953726 cites W2151603390 @default.
• W2135953726 cites W2152370183 @default.
• W2135953726 cites W2159122349 @default.
• W2135953726 cites W2165278596 @default.
• W2135953726 cites W2168956122 @default.
• W2135953726 cites W2171051269 @default.
• W2135953726 cites W2171539930 @default.
• W2135953726 cites W2259707068 @default.
• W2135953726 cites W2582524520 @default.
• W2135953726 doi "https://doi.org/10.1186/alzrt275" @default.
• W2135953726 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4255389" @default.
• W2135953726 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25478019" @default.
• W2135953726 hasPublicationYear "2014" @default.
• W2135953726 type Work @default.
• W2135953726 sameAs 2135953726 @default.
• W2135953726 citedByCount "23" @default.
• W2135953726 countsByYear W21359537262015 @default.
• W2135953726 countsByYear W21359537262016 @default.
• W2135953726 countsByYear W21359537262017 @default.
• W2135953726 countsByYear W21359537262018 @default.
• W2135953726 countsByYear W21359537262019 @default.
• W2135953726 countsByYear W21359537262020 @default.
• W2135953726 countsByYear W21359537262021 @default.
• W2135953726 countsByYear W21359537262022 @default.
• W2135953726 crossrefType "journal-article" @default.
• W2135953726 hasAuthorship W2135953726A5009252002 @default.
• W2135953726 hasAuthorship W2135953726A5018836358 @default.
• W2135953726 hasAuthorship W2135953726A5019926739 @default.
• W2135953726 hasAuthorship W2135953726A5025870220 @default.
• W2135953726 hasAuthorship W2135953726A5038926287 @default.
• W2135953726 hasAuthorship W2135953726A5039252548 @default.
• W2135953726 hasAuthorship W2135953726A5062479277 @default.
• W2135953726 hasAuthorship W2135953726A5064378373 @default.
• W2135953726 hasBestOaLocation W21359537261 @default.
• W2135953726 hasConcept C126322002 @default.
• W2135953726 hasConcept C134018914 @default.
• W2135953726 hasConcept C142724271 @default.
• W2135953726 hasConcept C15744967 @default.
• W2135953726 hasConcept C164705383 @default.
• W2135953726 hasConcept C204787440 @default.
• W2135953726 hasConcept C27081682 @default.
• W2135953726 hasConcept C2776332859 @default.
• W2135953726 hasConcept C2779056891 @default.
• W2135953726 hasConcept C2779134260 @default.
• W2135953726 hasConcept C2779483572 @default.
• W2135953726 hasConcept C2780904820 @default.
• W2135953726 hasConcept C2781172350 @default.
• W2135953726 hasConcept C42219234 @default.
• W2135953726 hasConcept C44249647 @default.
• W2135953726 hasConcept C57089818 @default.
• W2135953726 hasConcept C67761136 @default.
• W2135953726 hasConcept C71924100 @default.
• W2135953726 hasConceptScore W2135953726C126322002 @default.
• W2135953726 hasConceptScore W2135953726C134018914 @default.
• W2135953726 hasConceptScore W2135953726C142724271 @default.
• W2135953726 hasConceptScore W2135953726C15744967 @default.

• next